Live Quote · AMEXNNVCHealthcare· Biotechnology

NanoViricides, Inc.

$1.33 1.48%($-0.02)
TickerSpark Score
55/100
Mixed
70
Valuation
20
Profitability
40
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NNVC research report →

52-Week Range35% of range
Low
$0.85
Current
$1.33
High
$2.23
Company Overviewwww.nanoviricides.com

About the company

NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses.

CEO
Anil R. Diwan
IPO
2005
Employees
7
HQ
Shelton, CT, US

Price Chart

-4.32% · this period
$2.03$1.44$0.85Jul 02Dec 31Jul 02
Valuation
Market Cap
$23.77M
P/E
-3.08
P/S
0.00
P/B
3.14
EV/EBITDA
-2.73
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-92.69%
ROIC
-89.32%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-9,466,966 · -14.14%
EPS
$-0.63 · 10.00%
Op Income
$-9,591,645
FCF YoY
-31.88%
Performance & Tape
52W High
$2.23
52W Low
$0.85
50D MA
$1.44
200D MA
$1.29
Beta
1.67
Avg Volume
908.18K

Get TickerSpark's AI analysis on NNVC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 21, 17BONIUK MILTONother0
Feb 21, 17Stephenson Fournier, PLLCother0
Aug 8, 22Diwan Anilother94,471
Feb 7, 20Jawadakar Makarandother0
Jun 2, 19Day Mark D.other0
May 21, 18BONIUK MILTONother5,500,000
Feb 21, 17BONIUK MILTONother1,746,288
Jul 11, 17BONIUK MILTONother120,744
May 4, 17BONIUK MILTONother149,478
Feb 21, 17BONIUK MILTONother153,611
Coverage · NNVC

Our NNVC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NNVC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NNVC report →
Internal Compare

Similar companies

Peers in the same neighborhood.